155.     Whitty CWM. Migraine variants. Br Med J 1971;1:38.

156.     Gascon G, Barlow C. Juvenile migraine, presenting as an acute confusional state. Pediatrics 1970(45):628.

157.     Whitty CWM. Migraine without headache. Lancet 1967(2):283.

158.     Bigal ME, Sheftell FD, Rapoport AM, Lipton RB, Tepper SJ. Chronic daily headache in a tertiary care population:  correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for chronic daily headache. Cephalalgia 2002;22:432-8.

159.     Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache 1998;38:497-506.

160.     Mathew NT, Kurman R, Perez F. Drug induced refractory headache -- clinical features and management. Headache 1990;30:634-8.

161.     Silberstein SD, Lipton RB. Chronic daily headache. In: Goadsby PJ, Silberstein SD, eds. In Headache. Newton: Butterworth-Heinemann; 1997:201-25.

162.     Kuncle EC, Anderson WB. Significance of minor eye signs in headaches of migraine type. Arch Ophthalmol 1961;65:504.

163.     Bickerstaff EB. Cluster Headaches. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology. New York: American Elsevier; 1968:111-8.

164.     Eggleston DJ. Periodic migrainous neuralgia. Oral Surg 1970;29:524.

165.     Nelson RF. Cluster Migraine:  An unrecognized common entity. Can Med Assoc J 1970;103:1026.

166.     Lance JW, Anthony M. Migrainous neuralgia or cluster headache. J Neurol Sci 1971;13:401.

167.     Ekbom K. A clinical comparison of cluster headache and migraine. Acta Neurol Scand 1970;46(suppl. 41):1.

168.     Romberg MH. A Manual of the Nervous Disease of Man. Unknown 1853:56.

169.     Harris W. Neuritis and Neuralgia. Oxford: Oxford Univ.Press; 1926.

170.     Harris W. Ciliary (migrainous) neuralgia and its treatment. Br Med J 1938;1:457.

171.     Ekbom K, Greitz T. Carotid angiography in cluster headache. Acta Radiol 1970;10:177.

172.     Vail HH. Vidian neuralgia, with special reference to eye and orbital pain in suppuration of petrous apex. Ann Otolaryngol 1932;41:837.

173.     Aubry M, Pialoux P. Sluder's syndrome. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology. New York: American Elsevier; 1968:326-32.

174.     Raeder JG. "Paratrigeminal" paralysis of oculopupillary sympathetic. Brain 1924;47:149.

175.     Boniuk M, Schlezinger NS. Raeder's paratrigeminal syndrome. Am J Ophthalmol 1962;54:1074.

176.     Ford FR, Walsh FB. Raeder's paratrigeminal syndrome:  A benign disorder, possibly a complication of migraine. Bull Johns Hopkins Hosp 1958.

177.     Smith JL. Raeder's paratrigeminal syndrome. Am J Ophthalmol 1958;46:194.

178.     Davis RH, Daroff RB, Hoyt WF. Hemicrania, oculosympathetic paresis, and subcranial carotic aneurysm:  Raeder's paratrigeminal syndrome (Group 2). J Neurosurg 1968;29:94.

179.     Law WR, Nelson ER. Internal carotid aneurysm as a cause of Raeder's paratrigeminal syndrome. Neurology 1968;18(43).

180.     Cohen DN, Zakov ZN, Salanga VD, et.al. Raeder's paratrigeminal syndrome:  A new etiology. Am J Ophthalmol 1975;79:1044.

181.     Horton BT. Histaminic cephalgia:  Differential diagnosis and treatment. Proc Mayo Clin 1956;31:325.

182.     Meyer JS, Binns PM, Ericsson AD, et.al. Sphenopalatine ganglionectomy for cluster headache. Arch Otolaryngol 1970;92:475.

183.     Anthony M, Lance JW. Histamine and serotonin in cluster headache. Arch Neurol 1971;25:225.

184.     Graham JR. Methysergide for prevention of headache. N Engl J Med 1964;270:67.

185.     Weber RB, Reinmuth OM. The treatment of migraine with propranolol. Neurology 1972;22:366.

186.     Gelmers HJ. Nimodipine, a new calcium antagonist, in the prophylactic treatment of migraine. Headache 1983;23:106-9.

187.     Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic features, including new cases. Brain 1997;120:193-209.

188.     Goadsby PJ, Matharu MS, Boes CJ. SUNCT syndrome or trigeminal neuralgia with lacrimation. Cephalalgia 2001;21:82-3.

189.     Penart A, Firth M, Bowen JRC. Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) following presumed dorsolateral brainstem infarction. Cephalalgia 2001;21(236-239).

190.     Matharu MS, Levy MJ, Merry RT, Goadsby PJ. SUNCT syndrome secondary to prolactinoma. J Neurol Neurosurg Psych 2003;In Press.

191.     Vahlquist B. Migraine in children. Int Arch Allergy Appl Immunol 1955;7:348.

192.     Michael MI, Williams JM. Migraine in children. J Pediatr 1952;41:18.

193.     Krupp GR, Friedman AP. Recurrent headache in children:  A study of 100 clinical cases. NY State J Med 1933;53:43.

194.     Holguin J, Fenichel G. Migraine. J Pediatr 1967;70:290.

195.     Hachinski VC, Porchawka J, Steele JC. Visual symptoms in the migraine syndrome. Neurology 1973;23:570.

196.     Golden GS. The 'Alice in Wonderland Syndrome' in juvenile migraine. Pediatrics 1979;63:517.

197.     Haas DC, Souner RD. Migraine attacks triggered by mild head trauma and their relation to certain post-traumatic disorders of childhood. J Neurol Neurosurg Psych 1969;32:548.

198.     Griffith JF, Dodge PR. Transient blindness following head injury in children. N Engl J Med 1968;278:638.

199.     Greenblatt SH. Post-traumatic transient cerebral blindness:  Association with migraine and seizure diathesis. JAMA 1973;225:1073.

200.     Forsyth WI, Gillies D, Sills MA. Propanalol ('Inderal') in the treatment of childhood migraine. Develop Med & Child Neurol 1984;26:737-41.

201.     Hinrichs WL, Keith HM. Migraine in childhood:  A follow-up report. Mayo Clin Proc 1965;40:593.

202.     Diamond S, Dalessio DJ. The Practicing Physician's Approach to Headache. Baltimore: Williams & Wilkins; 1986.

203.     The Headaches. New York: Raven Press; 1993.

204.     Troost BT. Migraine and facial pain. In: Lessell S, Van Dalen JTW, eds. Current Neuro-Ophthalmology. New York: Year Book Medical Publishers; 1988:269-87.

205.     Troost BT, McCormick GM. Migraine and facial pain. In: Lessell S, Van Dalen JTW, eds. Current Neuro-Ophthalmology. Chicago: Year Book Medical Publishers; 1989:269-87.

206.     Swerdlow M. Anticonvulsant drugs and chronic pain. Clin Neuropharmacol 1984;7:51-82.

207.     Janetta PJ. Microsurgical approach to the trigeminal nerve for tic douloureaux. Progr Neurol Surg 1976;7:188-200.

208.     Janetta PJ. Microsurgical management of trigeminal neuralgia. Arch Neurol 1985;42:800.

209.     Zorman G, Wilson CB. Outcome following microsurgical vascular decompression or partial sensory rhizotomy in 125 cases of trigeminal neuralgia. Neurology 1984;34:1362-5.

210.     Sweet WH. The treatment of trigeminal neuralgia. N Engl J Med 1987;316:692-3.

211.     Allen NB, Studenski SA. Polymyalgia rheumatica and temporal arteritis. Med Clin N Amer 1986;79:369-84.

212.     Vilaseca J, Gonzalez A, Cid MC, et.al. Clinical usefulness of temporal artery biopsy. Ann Rheu Dis 1987;46:282-5.

213.     Soloman S, Cappa KG. The headache of temporal arteritis. J Am Geriatr Soc 1987;35:163-5.

214.     Allen NB, Studenski SA. Polymyalgia rheumatica and temporal arteritis. Med Clin N Am 1986;70:369-84.

215.     Currie J, Lessell S. Tonic pupil giant cell arteritis. Br J Ophthal 1984;68:135-8.

216.     Monteiro MLR, Coppeto JR, Greco P. Giant cell arterities of the posterior cerebral circulation presenting with ataxia and ophthalomoplegia. Arch Ophthalmol 1984;102:407-9.

217.     Howard GF, HO SU, Kim KS, et.al. Bilateral carotid artery occlusion resulting from giant cell arteritis. Ann Neurol 1984;15:204-7.

218.     Truong L, Kopelman RG, Williams GS, et.al. Temporal arteritis and renal disease. Am J Med 1985;78:171-5.

219.     Perruquet JL, Davis DE, Harrington TM. Aortic arch arteritis in the elderly: an important manifestation of giant cell arteritis. Arch Intern Med 1986;146:289-91.

220.     Selsky IJ, Nirankari VS. Temporomandibular joint pain as a manifestation of temporal arteritis. So Med J 1985;78:1249-51.

221.     Accetta DD, Kelley JF, Tubbs RR. An elderly black woman with a painful "swollen" face. Ann Allerg 1985;55:819-24.

222.     Goodman BW, Shepard FA. Jaw claudication. Its value as a diagnostic clue. Postgrad Med 1983;73:177-83.

223.     Save-Soderbergh J, Malmvall BE, Andersson R, et.al. Giant cell arteritis as a cause of death: report of nine cases. JAMA 1986;255:493-6.

224.     Wong RL, Korn JH. Temporal arteritis and normal sedimentation rates. Am J Med 1986;80:959-65.

225.     Villalta J, Estrach T. Temporal arteritis with normal erythrocyte sedimentation. Ann Intern Med 1985;(letter) 103:808.

226.     Plum F. Temporal arteritis with normal sedimentation rate. Neurology Alert 1986;4:46.

227.     Daroff RB. New headache classification. Neurology 1988;38:1138-9.

228.     Ziegle DK. Tension-muscle contraction headaches. A review. In: Pfaffenrath V, Lundberg PO, Sjaastad O, eds. Updating Headache. Berlin: Springer-Verlag; 1985:315-20.

229.     Jakobsen J, Baadsgaard SE, Thompsen S, et.al. Prediction of post-concussional sequelae by reaction time test. Acta Neurol Scan 1987;75:341-5.

230.     Leblanc R. The minor leak proceding subarachnoid hemorrahage. J Neurosurg 1987;66:35-9.

231.     Mokri B, Sundt TM, Houser OW, et.al. Spontaneous dissection of the cervical internal carotid artery. Ann Neurol 1986;19:126-38.

232.     Carlow TJ. Headache and the eye. In: Dalessio DJ, ed. Wolff's Headache and other Head Pain. New York: Oxford Univ.Press; 1987:304-20.

233.     Vinken PJ, Bruyn GW. Handbook of Clinical Neurology. New York: American Elsevier; 1968.

234.     Francis KR, Williams DP, Troost BT. Facial numbness and dysesthesia. Arch Neurol 1987;44:345-6.

235.     Dalessio DJ. Diagnosing the severe headache. Neurology 1994;(Suppl. 3) 44:6-12.

236.     Pincus JH, Daroff RB. Sphenoid sinus mucocele: A curable cause of the ophthalmoplegic migraine syndrome. JAMA 1964;187:459.

237.     Baumel B. Migraine: A pharmacologic review with newer options and delivery modalities. Neurology 1994;(Suppl. 3) 44:13-7.

238.     Edmeads J. Advances in migraine therapy: Focus on oral sumatriptan. Neurology 1995;(Suppl. 7) 45:3-4.

239.     Cutler N, Mushet GR, Davis R, Clements B, Whitcher L. Oral sumatriptan for the acte treatment of migraine: Evaluation of three dosage strengths. Neurology 1995;(Suppl. 7) 45:5-9.

240.     Sargent J, Kirchner JR, Davis R, Kirkhart B. Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: Results of a multicenter study. Neurology 1995;(Suppl. 7) 45:10-4.

241.     Rederich G, Rapoport A, Cutler N, Hazelrigg R, Jamerson B. Oral sumatriptan for the long-term treatment of migraine: Clinical findings. Neurology 1995;(Suppl. 7) 45:15-20.

242.     Troost BT. Botulinum Toxin Type A (BoNT-A) in the Treatment of Migraine and Other Headaches. Neurotherapeutics Expert Rev 2004:In Press.

243.     Blumenfeld A. Botulinum Toxin Type A as an Effective Prophylactic Treatment in Primary Headache Disorders. Headache 2003;43:853-60.

244.     Blumenfeld AM, Binder W, Silberstein SD, Blitzer A. Procedures for Administering Botulinum Toxin Type A for Migraine and Tension-type Headache. Headache 2003;2003:884-91.

245.     Ryan RE. A study of Midrin in the symptomatic relief of migraine headache. Headache 1974;14:33-42.

246.     Tfelt-Hansen P, Lipton RB. Miscellaneous drugs. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches. New York: Raven Press; 1993:353-8.

247.     Humphrey PPA, Feniuk W, Perren MJ. Anti-Migraine drugs in development: advances in serotonin receptor pharmacology. Headache 1990;(Suppl. 1) 30:12.

248.     Peroutka SJ. Developments in 5-hydroxytryptamine receptor pharmacology in migraine. Neurol Clin 1990;8:829-38.

249.     Peroutka SJ. The pharmacology of current antimigraine drugs. Headache 1990;(Suppl. 1) 30:12.

250.     Callaham M, Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache 1986;26:168-71.

251.     Silberstein SD. Review: serotonin 5-HT and migraine. Headache 1994;34:408-17.

252.     Silberstein SD, Saper J. Migraine: diagnosis and treatment. In: Dalessio D, Silberstein SD, eds. Wolff's Headache and other head pain. 6 ed. New York: Oxford University Press; 1993:96-170.

253.     Wilkinson M. Migraine: Treatment of acute attack. Br Med J 1971;2:754.

254.     Goodman LS, Gilman A. The Pharmacological Basis of Therapeutics. 8 ed. New York: Pergamon Press, Inc.; 1990.

255.     Raskin NH, Raskin KE. Repetitive intravenious dihydroergotamine for the treatment of intractable migraine. Neurology 1984;34 (suppl. 1):245.

256.     Sanders SW, Haering N, Mosberg H, et.al. Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing. Eur J Clin Pharmacol 1986;30:331-4.

257.     Volans GN. Research review: migraine and drug absorption. Clin Pharmacokinet 1978;3:313-8.

258.     Sicuteri F, Franchi G, Del Bianco PL. An antaminic drug, BC-105, in the prophylaxis of migraine. Int Arch Allergy Appl Immunol 1967;31:78.

259.     Tfelt-Hansen P, Saxena PR, Dahlof C, et.al. Ergotamine in the acute treatment of migraine:  a review and European consensus. Brain 2000;123:9-18.

260.     Olesen J, Tfelt-Hansen P, Welch KMA. The headaches. 2 ed. Phildelphia: Lippincott Williams & Wilkins; 2000.

261.     Welch KMA, Mathew NT, Stone P, Rosamond W, Saiers J, Guttermann D. Tolerability of sumatriptan:  clinical trials and post-marketing experience. Cephalalgia 2000;20:687-95.

262.     Goadsby PJ. The pharmacology of headache. Prog Neurobiol 2000;62:509-25.

263.     Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Triptans (serotonin, 5-HT 1b/1D agonists) in acute migraine treatment: a meta analysis of 53 trials. Lancet 2001;358:1668-75.

264.     Goadsby PJ, Ferrari MD, Olesen J, et.al. Eletriptan in acute migraine:  a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee. Neurology 2000;54:156-63.

265.     Mathew NT, Schoenen J, Winner P, Muirhead N, Sikes CR. Compartive efficacy of eletriptan 40 mg versus sumatriptan 100 mg. Heachache 2003;43:214-22.

266.     Lipton RB, Stewart WF, Stone AM, Lainez MJA, Sawyer JPC. Disability in Strategies of Care Study Group.  Stratified care vs. step care strategies for migraine: the Disability in Strategies of Care (DISC) Study:  a randomized trial. JAMA 2000;284:2599-605.

267.     Slugg PH, Kunkel RS. Complications of methysergide therapy: Retroperitoneal fibrosis, mitral regurgitation, edema, and hemolytic anemia. JAMA 1970;213:297.

268.     Cortelli P, Sacquegna T, Albani F, et.al. Propranolol plasma levels and relief of migraine. Relationship between plasma propranolol and 4-hydroxyproranolol concentrations and clinical effects. Arch Neurol 1985;42:46-8.

269.     Troost BT, Wiles RM. Levetiracetam (LEV) for Treatment of Intractable Headache. Headache 2003;43(5):588.

270.     Solomon GD, Steel JD, Spaccavento LJ. Verapamil prophylaxis of migraine. A double-blind, placebo- controlled study. JAMA 1983;250:2500-2.

271.     Kahan A, Weber S, Amor B, et.al. Nifedipine in the treatment of migraine in patients with Raynaud's phenomenon. NEJM 1983;308:1102-3.

272.     Meyer JS, Hardenberg J. Clinical effectiveness of calcium entry blockers in prophylactic treatment of migraine and cluster headaches. Headache 1983;23:266-77.

273.     Lance JW. Headache. Ann Neurol 1981;10:1.

274.     Havanka-Kanniainen H, Hokkanen E, Myllyla VV. Efficacy of minodipine in the prophylaxis of migraine. Cephalalgia 1985;5:38-43.

275.     Louis P. A double-blind placebo-controlled prophylactic study of flunarizine (Sibelium) in migraine. Headache 1981;21:235-9.

276.     Amery WK, Caers LI, Aerts TJL. Flunarizine, a calcium entry blocker in migraine prophylaxis. Headache 1985;25:249-54.

277.     Ryan Sr RE, Ryan Jr RE, Sudilovsky A. Nadolol: its use in the prophylactic treatment of migraine. Headache 1983:23-6.

278.     Andersson K, Vinge E. -Adrenoceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine. Drugs 1990;39:355-73.

279.     Daroff RB, Whitney CM. Treatment of vascular headaches. Headache 1986;26:470-2.

280.     Ziegler DK, Hurwitz A, Hassanein RS, et.al. Migraine prophylaxis - a comparison of propranolol and amitriptyline. Arch Neurol 1987;44:486-9.

281.     Diamond S, Solomon GD, Freitag FG, et.al. Long-acting propranolol in the prophylaxis of migraine. Headache 1987;27:70-2.

282.     Elkind AH, Friedman AP, Bachman A, et.al. Silent retroperitoneal fibrosis associated with methysergide therapy. JAMA 1968;206:1041-4. 

283.     Graham J. Cardiac and pulmonary fibrosis during methysergide therapy for headache. Am J Med Sci 1967;254:1-12.

284.     Lipton SA. Prevention of classic migraine headache by digital massage of the superficial temporal arteries during visual aura. Ann Neurol 1986;19:515-6.

285.     Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum toxin type A as a migraine preventative treatment. Headache 2000;40(6):445-50.

286.     Troost BT, Rosenberg JR, Wiles R. Improvement in Intractable Headache with Repeated Botulinum Toxin Type A Treatment. Neurology 2003;60 (Suppl 1)(5):A323.

287.     Cui M, Khanijou S, Rubino J, Aoki KR. Botulinum toxin A inhibits the inflammatory pain in the rat formalin model. In: Abstracts of the 30th Annual Meeting of the Society for Neuroscience, November 4-9.  Available at: http://sfn.scholarone.com/itin2000/main.html. (abstract 246.2). 2000.

288.     Ishikawa H, Mitsui Y, Yoshitomi T, et al. Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles. Jpn J Ophthalmol 2000;44:106-9.

289.     Welch MJ, Purkiss JR, Foster KA. Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicol 2000;38:245-58.